Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
BrainFulness
BrainFulness Overview
BrainFulness has developed a new technology for treating major depression, ADHD, and dementia. The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan.
The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects.